One or three weeks' treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam.

Author: BauerC A, JerneliusH, ZbornikJ

Paper Details 
Original Abstract of the Article :
The clinical and bacteriological effects of 1 and 3 weeks' pivampicillin plus pivmecillinam treatment were compared in a double-blind, randomized study of patients with acute pyelonephritis. Three weeks after the end of active treatment, clinical success was seen in 29 (91%) of the 32 patients on 1-...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.0954-6820.1988.tb15899.x

データ提供:米国国立医学図書館(NLM)

Treating Acute Pyelonephritis: Duration Matters

The field of infectious diseases is constantly seeking new and effective treatments for bacterial infections. This study compares the efficacy of one-week versus three-week treatment with a fixed combination of pivampicillin plus pivmecillinam for patients with acute pyelonephritis, a serious kidney infection. The researchers conducted a double-blind, randomized trial to evaluate the effectiveness of these treatment durations.

The study found that while both one-week and three-week treatment durations resulted in similar clinical success rates, the three-week treatment was significantly more effective in achieving bacteriological success. The researchers observed a higher rate of relapses in the one-week group, particularly lower urinary tract infections. The authors concluded that one-week treatment is insufficient for achieving bacteriological success in patients with acute pyelonephritis, while three-week treatment is more effective but may be associated with higher rates of side effects.

Three Weeks of Treatment: A More Effective Approach?

The study's findings highlight the importance of adequate treatment duration for achieving bacteriological success in patients with acute pyelonephritis. The researchers recommend that healthcare providers carefully consider the individual risks and benefits of treatment duration when making treatment decisions.

Health Implications and Lifestyle Considerations

The study underscores the importance of completing the full course of antibiotic treatment as prescribed by a healthcare provider. The researchers emphasize that premature discontinuation of antibiotics can lead to treatment failure and the development of antibiotic resistance. The study also highlights the need for close monitoring of patients with acute pyelonephritis, particularly for signs of relapse.

Dr.Camel's Conclusion

The battle against bacterial infections is a constant fight, like the struggle of a desert nomad against the unforgiving elements. This study underscores the importance of adequate treatment duration in achieving bacteriological success in patients with acute pyelonephritis. It serves as a reminder to follow the guidance of healthcare professionals and complete the full course of antibiotics as prescribed, ensuring that the battle against infection is won.

Date :
  1. Date Completed 1988-07-08
  2. Date Revised 2022-03-17
Further Info :

Pubmed ID

3287839

DOI: Digital Object Identifier

10.1111/j.0954-6820.1988.tb15899.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.